This issue of PATH Today focuses on the launch of the MenAfriVac™ vaccine, the first meningitis vaccine created specifically for Africa. The issue includes a timeline of meningitis in Africa and the development of the vaccine, how PATH partnered with other organizations to create an affordable solution, and a glimpse of what life is like in the "meningitis belt."
Corporate author(s): PATH
Publication date: December 2010
1,210 KB PDF
Some digital files may be saved at low resolutions to conserve file size. Versions with higher quality may be available; see the contact information below to enquire.
This publication is part of the series PATH Today
Related regions: Global
See also: Vaccines and immunization > Meningitis
For more information…
Contact: PATH Publications
Mailing address: PATH, PO Box 900922, Seattle, WA 98109 USA